Tamoxifen in antiretroviral-associated gynaecomastia.
Gynaecomastia arising in the context of antiretroviral therapy for HIV infection presents a number of challenges in diagnosis and management. We describe a thirty year old gay man with rapidly developing breast enlargement who was successfully treated with the anti-oestrogen tamoxifen.
Department of Genitourinary Medicine, St George's Hospital, London SW17 0QT, UK.
Stephen
S
Kegg
Richard
R
Lau
D000328:Adult; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use*; D006177:Gynecomastia / Q000139:chemically induced / Q000188:drug therapy*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D019290:Megestrol Acetate / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013629:Tamoxifen / Q000627:therapeutic use*; D019562:Viral Load
D020847:Estrogen Receptor Modulators; D018894:Reverse Transcriptase Inhibitors; D013629:Tamoxifen; D019290:Megestrol Acetate